Astek is a precision diagnostics company which is developing the Jiddu system to confirm bacterial infections and assess antibiotic sensitivity across multiple sample types: urine, CSF, effluent, and blood. Astek has prioritized going to market in 2025 with a urine-based test focused on UTIs. The company operates on a razor-razorblade business model and has already signed numerous LOIs for product deployment with hospitals and urology practices.